Next - Gen Immuno Oncology Conference

5th - 6th October 2023

Frankfurt, Germany

Transforming cancer care through innovative immunotherapies

Over the past 6 years, Marketsandmarkets Next-Gen Immuno-Oncology conference has become the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncology. Marketsandmarkets IO congress provides access to a comprehensive 2-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies, appraise AI and computational tools for the discovery of new targets, target classes, and combinations to overcome resistance.

Our inaugral MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 5th – 6th October 2023, in Frankfurt, would address the challenges and future directions in IO research.

This conference will highlight the current state of immuno-oncology for cancer care professionals with emphasis on current research, utilization trends, and advances in immunotherapies. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, biopharma and biotech companies, the congress will discuss the latest updates in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy


  • Updates in development of ADC’s and Bispecific Ab’s
  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
  • Biomarkers and Personalized Medicine in IO
  • CAR-T Cell therapy, TCR Based-Cell Therapy
  • Tumour microenvironment and Oncolytic Viruses

  • Exclusive conference to learn about antibodies, cellular therapy, and immune-checkpoint research under one roof.
  • Find out new case studies of immune-oncology projects in development.
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you.
  • Explore the latest platforms and technologies on the market for development.
  • Discuss the best tool for your research in immune oncology.
  • Share your work and achievements with your industry peers in the Poster Session

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

  • Monoclonal and Bispecific Antibodies
  • Cell Therapy
  • Immune Checkpoint Inhibitors




Frankfurt, Germany